1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Breast Lesion Localization Methods Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Breast Lesion Localization Methods Market Revenue and Volume, by Technique
8.1.1. Wire Localization
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Radioisotope Localization (ROLL)
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Magnetic Seed Localization
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Radar Localization
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Radiofrequency Identification (RFID) Localization
8.1.5.1. Market Revenue and Volume Forecast
9.1. Breast Lesion Localization Methods Market Revenue and Volume, by Product
9.1.1. Localization Wires
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Localization Seeds
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Localization Tags & Markers
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Accessories
9.1.4.1. Market Revenue and Volume Forecast
10.1. Breast Lesion Localization Methods Market Revenue and Volume, by Imaging Guidance
10.1.1. Mammography-guided
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Ultrasound-guided
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. MRI-guided
10.1.3.1. Market Revenue and Volume Forecast
11.1. Breast Lesion Localization Methods Market Revenue and Volume, by End-Use
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Ambulatory Surgical Centers
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Diagnostic Imaging Centers
11.1.3.1. Market Revenue and Volume Forecast
12.1. Breast Lesion Localization Methods Market Revenue and Volume, by Application
12.1.1. Breast Cancer Surgery
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Biopsy Procedures
12.1.2.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Technique
13.1.2. Market Revenue and Volume Forecast, by Product
13.1.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.1.4. Market Revenue and Volume Forecast, by End-Use
13.1.5. Market Revenue and Volume Forecast, by Application
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Technique
13.1.6.2. Market Revenue and Volume Forecast, by Product
13.1.6.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.1.6.4. Market Revenue and Volume Forecast, by End-Use
13.1.6.5. Market Revenue and Volume Forecast, by Application
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Technique
13.1.7.2. Market Revenue and Volume Forecast, by Product
13.1.7.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.1.7.4. Market Revenue and Volume Forecast, by End-Use
13.1.7.5. Market Revenue and Volume Forecast, by Application
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Technique
13.2.2. Market Revenue and Volume Forecast, by Product
13.2.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.2.4. Market Revenue and Volume Forecast, by End-Use
13.2.5. Market Revenue and Volume Forecast, by Application
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Technique
13.2.6.2. Market Revenue and Volume Forecast, by Product
13.2.6.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.2.7. Market Revenue and Volume Forecast, by End-Use
13.2.8. Market Revenue and Volume Forecast, by Application
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Technique
13.2.9.2. Market Revenue and Volume Forecast, by Product
13.2.9.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.2.10. Market Revenue and Volume Forecast, by End-Use
13.2.11. Market Revenue and Volume Forecast, by Application
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Technique
13.2.12.2. Market Revenue and Volume Forecast, by Product
13.2.12.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.2.12.4. Market Revenue and Volume Forecast, by End-Use
13.2.13. Market Revenue and Volume Forecast, by Application
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Technique
13.2.14.2. Market Revenue and Volume Forecast, by Product
13.2.14.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.2.14.4. Market Revenue and Volume Forecast, by End-Use
13.2.15. Market Revenue and Volume Forecast, by Application
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Technique
13.3.2. Market Revenue and Volume Forecast, by Product
13.3.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.3.4. Market Revenue and Volume Forecast, by End-Use
13.3.5. Market Revenue and Volume Forecast, by Application
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Technique
13.3.6.2. Market Revenue and Volume Forecast, by Product
13.3.6.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.3.6.4. Market Revenue and Volume Forecast, by End-Use
13.3.7. Market Revenue and Volume Forecast, by Application
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Technique
13.3.8.2. Market Revenue and Volume Forecast, by Product
13.3.8.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.3.8.4. Market Revenue and Volume Forecast, by End-Use
13.3.9. Market Revenue and Volume Forecast, by Application
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Technique
13.3.10.2. Market Revenue and Volume Forecast, by Product
13.3.10.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.3.10.4. Market Revenue and Volume Forecast, by End-Use
13.3.10.5. Market Revenue and Volume Forecast, by Application
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Technique
13.3.11.2. Market Revenue and Volume Forecast, by Product
13.3.11.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.3.11.4. Market Revenue and Volume Forecast, by End-Use
13.3.11.5. Market Revenue and Volume Forecast, by Application
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Technique
13.4.2. Market Revenue and Volume Forecast, by Product
13.4.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.4.4. Market Revenue and Volume Forecast, by End-Use
13.4.5. Market Revenue and Volume Forecast, by Application
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Technique
13.4.6.2. Market Revenue and Volume Forecast, by Product
13.4.6.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.4.6.4. Market Revenue and Volume Forecast, by End-Use
13.4.7. Market Revenue and Volume Forecast, by Application
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Technique
13.4.8.2. Market Revenue and Volume Forecast, by Product
13.4.8.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.4.8.4. Market Revenue and Volume Forecast, by End-Use
13.4.9. Market Revenue and Volume Forecast, by Application
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Technique
13.4.10.2. Market Revenue and Volume Forecast, by Product
13.4.10.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.4.10.4. Market Revenue and Volume Forecast, by End-Use
13.4.10.5. Market Revenue and Volume Forecast, by Application
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Technique
13.4.11.2. Market Revenue and Volume Forecast, by Product
13.4.11.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.4.11.4. Market Revenue and Volume Forecast, by End-Use
13.4.11.5. Market Revenue and Volume Forecast, by Application
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Technique
13.5.2. Market Revenue and Volume Forecast, by Product
13.5.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.5.4. Market Revenue and Volume Forecast, by End-Use
13.5.5. Market Revenue and Volume Forecast, by Application
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Technique
13.5.6.2. Market Revenue and Volume Forecast, by Product
13.5.6.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.5.6.4. Market Revenue and Volume Forecast, by End-Use
13.5.7. Market Revenue and Volume Forecast, by Application
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Technique
13.5.8.2. Market Revenue and Volume Forecast, by Product
13.5.8.3. Market Revenue and Volume Forecast, by Imaging Guidance
13.5.8.4. Market Revenue and Volume Forecast, by End-Use
13.5.8.5. Market Revenue and Volume Forecast, by Application
14.1. Hologic
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BD (Becton Dickinson)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Cook Medical
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Merit Medical Systems
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Argon Medical Devices
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. SOMATEX Medical Technologies
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Endomagnetics
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Cianna Medical
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. IZI Medical Products
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Theragenics Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at [email protected]
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client